JP Morgan analyst Andrea Teixeira maintained Colgate-Palmolive with an Overweight rating and raised the price target from $95 ...

Calling all income investors! Two dividend kinds deserve your attention in 2025: Colgate-Palmolive (NYSE:CL) and Emerson ...

Colgate-Palmolive (CL) reported better-than-expected earnings for the first quarter of 2025, despite a decline in net sales. The consumer goods ...

Colgate-Palmolive posted a higher profit in the first quarter but lowered 2025 earnings guidance due to tariffs.

The owner of skin care brand Sanex is also expecting a price hike on sold goods as a result of US President Donald Trump’s global tax hikes ...

We look at Colgate-Palmolive Company's Q1 results, market challenges, and tariff impacts. Read to see if the CL stock is ...

Colgate-Palmolive on Friday reported better-than-expected first-quarter results and lifted its full-year sales outlook, ...

Organic sales rose 1.4% during the quarter, with pricing up 1.5% and volume down 0.1%. The impact of FX was a negative 4.4% ...

Palmolive reported quarterly results that beat Wall Street estimates and raised its annual sales forecast on Friday, banking ...

Colgate-Palmolive surpassed earnings expectations in Q1 2025, despite experiencing a decline in overall sales.

Makers of our food and home essentials, including Pepsi and Procter & Gamble, are cutting their financial forecasts for the ...